Abstract
A study was conducted to confirm the efficacy of topical eprinomectin against nematodes and to evaluate the pharmacokinetics in cattle prevented from having physical contact with other cattle and from self-grooming. Sixteen male Brown Swiss calves were infected with larvae of recently isolated nematode parasites. Inoculation was scheduled so that the nematodes were expected to be adults at the time of treatment. Animals were blocked based on pretreatment body weight and randomly allocated to the untreated control group or the group treated with EPRINEX® Pour-On (Merial; 0.5 mg eprinomectin per kilogram body weight). Plasma samples were collected prior to and between 1 and 21 days following treatment and analysed for eprinomectin (B1a component) concentrations. For parasite recovery, identification and counting, animals were humanely euthanized 21 days after treatment. Calves treated with eprinomectin had significantly (p < 0.05) fewer (>99 % reduction) adult Dictyocaulus viviparus, Bunostomum phlebotomum, Cooperia oncophora, Cooperia surnabada, Cooperia punctata, Nematodirus helvetianus, Oesophagostomum radiatum, Ostertagia ostertagi, Ostertagia lyrata, and Trichostrongylus axei and inhibited fourth-stage Nematodirus and Ostertagia larvae than the controls. The main pharmacokinetic parameters of eprinomectin B1a were: AUC(inf), 124 ± 24 day ng/mL; T 1/2, 5.2 ± 0.9 days; and C max, 9.7 ± 2.2 ng/mL. Individual maximal concentrations were observed 3–7 days after treatment. This study confirmed the continued high level of efficacy of topically administered eprinomectin against a wide range of recently isolated nematodes. In addition, this study demonstrates that oral ingestion is not required to achieve adequate exposure for efficacy following topical administration of eprinomectin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvinerie M, Sutra JF, Galtier P, Mage C (1999) Pharmacokinetics of eprinomectin in plasma and milk following topical administration to lactating dairy cattle. Res Vet Sci 67:229–232
Barth D, Hair JA, Kunkle BN, Langholff WK, Löwenstein M, Rehbein S, Smith LL, Eagleson JS, Kutzer E (1997) Efficacy of eprinomectin against mange mites in cattle. Am J Vet Res 58:1257–1259
Bousquet-Mélou A, Mercadier S, Alvinerie M, Toutain P-L (2004) Endectocide exchanges between grazing cattle after pour-on administration of doramectin, ivermectin and moxidectin. Int J Parasitol 34:1299–1307
Bousquet-Mélou A, Jacquiet P, Hoste H, Clément J, Bergeaud JP, Alvinerie M, Toutain P-L (2011) Licking behaviour induces partial anthelmintic efficacy of ivermectin pour-on formulation in untreated cattle. Int J Parasitol 41:563–569
Cramer LG, Eagleson JS, Farrington DO (1997) The use of eprinomectin pour on formulation against endoparasite infections in cattle. Abstracts of the 16th World Association for the Advancement of Veterinary Parasitology Conference, 10–15 August 1997, Sun City, South Africa, p 18
Cramer LG, Pitt SR, Rehbein S, Gogolewski RP, Kunkle BN, Langholff WK, Bond KA, Maciel AE (2000) Persistent efficacy of topical eprinomectin against nematode parasites in cattle. Parasitol Res 86:944–946
Gogolewski RP, Slacek B, Familton AS, Paterson B, Langholff WK, Allerton GR, McAnulty R, Eagleson JS (1997) Efficacy of a topical formulation of eprinomectin against endoparasites of cattle in New Zealand. New Zealand Vet J 45:1–3
Holste JE, Smith LL, Hair JA, Lancaster JL, Lloyd JE, Langholff WK, Barrick RA, Eagleson JS (1997) Eprinomectin: a novel avermectin for control of lice in all classes of cattle. Vet Parasitol 73:153–161
Holste JE, Bowman D, Wallace D, Cramer L, Maciel A, Soll M (2002) Persistent activity of eprinomectin against trickle infections of Cooperia species in cattle. Abstracts of the 22nd World Buiatrics Congress, 18–23 August 2002, Hannover, Germany, p 159
Laffont CM, Alvinerie M, Bousquet-Mélou A, Toutain P-L (2001) Licking behaviour and environmental contamination arising from pour-on ivermectin in cattle. Int J Parasitol 31:1687–1692
Laffont CM, Bousquet-Mélou A, Bralet D, Alvinerie M, Fink-Gremmels J, Toutain P-L (2003) A pharmacokinetic model to document the actual disposition of topical ivermectin in cattle. Vet Res 34:445–460
Lumaret J-P, Errouissi F, Galtier P, Alvinerie M (2005) Pour-on formulation of eprinomectin for cattle: fecal elimination profile and effects on the development of the dung-inhabiting Diptera Neomyia cornicina (L.) (Muscidae). Env Toxicol Chem 24:797–801
Pitt SR, Langholff WK, Eagleson JS, Rehbein S (1997) The efficacy of eprinomectin against induced infections of immature (fourth larval stage) and adult nematode parasites in cattle. Vet Parasitol 73:119–128
Pollmeier M, Maier S, Moriarty K, DeMontigny P (2002) High-performance liquid chromatographic assay for the determination of a semisynthetic avermectin analog (eprinomectin) in bovine milk at parts per billion levels—method development and validation. J Chromat B772:99–105
Rehbein S, Pitt SR, Rossi L, Pollmeier M (2005a) Efficacy of eprinomectin against Linognathus vituli and Bovicola bovis on calves. Vet Rec 156:112–113
Rehbein S, Winter R, Visser M, Maciel AE, Marley SE (2005b) Chorioptic mange in dairy cattle: treatment with eprinomectin pour-on. Parasitol Res 98:21–25
Sallovitz JM, Lifschitz A, Imperiale F, Virkel G, Larghi J, Lanusse C (2005) Doramectin concentration profiles in the gastrointestinal tract of topically-treated calves: influence of animal licking restriction. Vet Parasitol 133:61–70
Shoop W, Soll M (2002) Ivermectin, abamectin and eprinomectin. In: Vercruysse J, Rew R (eds) Macrocyclic lactones in antiparasitic therapy. CABI Publishing, Oxon, pp 1–29
Shoop WL, Egerton JR, Eary CH, Haines HW, Michael BF, Mrozik H, Eskola P, Fisher MH, Slayton L, Ostlind DA, Skelly BJ, Fulton RK, Barth D, Costa S, Gregory LM, Campbell WC, Seward RL, Turner MJ (1996) Eprinomectin: a novel avermectin for use as a topical endectocide for cattle. Int J Parasitol 26:1237–1242
Vercruysse J, Rew R (2002) General efficacy of the macrocyclic lactones to control parasites of cattle. In: Vercruysse J, Rew RS (eds) Macrocyclic lacotes in antiparasitic therapy. CABI Publishing, Oxon, pp 185–222
Vercruysse J, Holdsworth P, Letonja T, Barth D, Conder G, Hamamoto K, Okano K (2001) International harmonisation of anthelmintic efficacy guidelines. Vet Parasitol 96:171–193
Wen H, Pan B, Wang Y, Wang F, Yang Z, Wang M (2010) Plasma and milk kinetics of eprinomectin following topical or oral administration to lactating Chinese Holstein cows. Vet Parasitol 174:72–76
Williams JC, Stuedemann JA, Bairden K, Kerboeuf D, Ciordia H, Hubert J, Broussard SD, Plue RE, Alva-Valdes R, Baggott DG, Pinkall N, Eagleson JS (1997) Efficacy of a pour-on formulation of eprinomectin (MK-397) against nematode parasites of cattle, with emphasis on inhibited early fourth-stage larvae of Ostertagia spp. Am J Vet Res 58:379–383
Wood IB, Amaral NK, Bairden K, Duncan JL, Kassai T, Malone JB Jr, Pankavich JA, Reinecke RK, Taylor SM, Vercruysse J (1995) World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine). Vet Parasitol 58:181–213
Author information
Authors and Affiliations
Corresponding author
Additional information
EPRINEX® is a registered trademark of Merial. All other marks are the property of their respective owners.
Rights and permissions
About this article
Cite this article
Rehbein, S., Visser, M., Kellermann, M. et al. Reevaluation of efficacy against nematode parasites and pharmacokinetics of topical eprinomectin in cattle. Parasitol Res 111, 1343–1347 (2012). https://doi.org/10.1007/s00436-012-2970-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-012-2970-2